Home

ERIC DOBMEIER

CIK 1202785 · President, CEO · last filed 2026-06-18

ERIC DOBMEIER is a President, CEO who has filed 129 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for GPCR, was dated Jun 18, 2026. Across all open-market trades the lifetime net is −$38.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $442.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$442.1K

Companies

9

Total Filings

129

Lifetime Open-Market Net

-$38.16M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GPCR Director — $47.89 — $0 3 2026-06-18
JANX Director 15,481 $15.00 $232.2K $0 4 2026-06-12
JBIO Director — $19.70 — $0 2 2026-06-11
ATRA Director 22,533 $7.81 $176.0K $236.9K 13 2023-11-14
CHINOOK THERAPEUTICS, INC. (KDNY) Delisted President, CEO 0 $40.39 $0 -$1.79M 22 2023-08-11
ADPT Director 1,504 $22.52 $33.9K -$2.70M 12 2021-02-17
Aravive, Inc. (VSAR) Delisted Director 3,027 — — $0 2 2017-12-22
Seagen Inc. (SGEN) Delisted Chief Operating Officer 117,424 $228.74 $26.86M -$33.92M 66 2017-12-06
STEMLINE THERAPEUTICS INC (STML) Delisted Director 27,963 — — $0 4 2017-06-20

Recent Filings

129 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-18 GPCR Grant (A) — $0 EDGAR
2026-06-12 JANX Grant (A) +5,500 $0 EDGAR
2026-06-11 JBIO Grant (A) — $0 EDGAR
2025-06-25 GPCR Grant (A) — $0 EDGAR
2025-06-13 JANX Grant (A) +3,750 $0 EDGAR
2025-05-01 JBIO Grant (A) — $0 EDGAR
2024-07-24 JANX Grant (A) +1,231 $0 EDGAR
2024-07-22 JANX Grant (A) +7,500 $0 EDGAR
2024-06-27 GPCR Grant (A) — $0 EDGAR
2023-11-14 ATRA Buy (P) +446,825 $101.3K EDGAR
Showing 1–10 of 129
Page 1 of 13
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.